AngioDynamics ANGO Accounts Receivable
Accounts Receivable at other companies
Other financials
Where this comes from
Reported directly by AngioDynamics in its filing.
Tagged under the XBRL concept us-gaap:AccountsReceivableNetCurrent.
The official record: AngioDynamics’s 10-Q, filed April 2, 2026, on SEC EDGAR. View the filing →
Ask your AI about AngioDynamics's accounts receivable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is AngioDynamics's accounts receivable?
- AngioDynamics (ANGO) reported accounts receivable of $45.55M in Q4 2025.
- How has AngioDynamics's accounts receivable changed year-over-year?
- AngioDynamics's accounts receivable increased by 4.8% year-over-year, from $43.47M to $45.55M.
- What is the long-term trend for AngioDynamics's accounts receivable?
- Over 4 years (2021 to 2025), AngioDynamics's accounts receivable has grown at a 4.9% compound annual growth rate (CAGR), from $35.41M to $42.89M.
- What does accounts receivable mean?
- Amounts owed by customers for goods delivered or services performed, net of allowances for doubtful accounts. A key working capital component.